Lv1
28 积分 2026-01-24 加入
ArenaissanceintargetingthePI3K/AKT/mTOR pathway
24天前
已完结
Effects of Sacubitril Valsartan Combined With Vericiguat on NT-proBNP and CK-MB Levels in Patients With Chronic Heart Failure
28天前
已完结
Insights Into Vepdegestrant (ARV-471): The First-in-Class Estrogen Receptor Proteolysis-Targeting Chimera Approaching Food and Drug Administration Approval for Breast Cancer
1个月前
已完结
Novel drugs approved by the EMA, the FDA and the MHRA in 2024: A year in review
2个月前
已完结
Novel drugs approved by the EMA, the FDA and the MHRA in 2025: A year in review
2个月前
已完结
Top companies and drugs by sales in 2025
2个月前
已关闭
皖公网安备34019202002308
